Logo image of Z

ZILLOW GROUP INC - C (Z) Stock Fundamental Analysis

NASDAQ:Z - Nasdaq - US98954M2008 - Common Stock - Currency: USD

78.01  -0.9 (-1.14%)

After market: 78.05 +0.04 (+0.05%)

Fundamental Rating

4

Overall Z gets a fundamental rating of 4 out of 10. We evaluated Z against 65 industry peers in the Real Estate Management & Development industry. Z has a great financial health rating, but its profitability evaluates not so good. Z is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

Z had positive earnings in the past year.
Z had a positive operating cash flow in the past year.
In the past 5 years Z always reported negative net income.
Of the past 5 years Z 4 years had a positive operating cash flow.
Z Yearly Net Income VS EBIT VS OCF VS FCFZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

1.2 Ratios

With a Return On Assets value of -1.41%, Z perfoms like the industry average, outperforming 49.23% of the companies in the same industry.
Z has a Return On Equity (-1.70%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -1.41%
ROE -1.7%
ROIC N/A
ROA(3y)-1.95%
ROA(5y)-2.59%
ROE(3y)-2.68%
ROE(5y)-4.27%
ROIC(3y)N/A
ROIC(5y)N/A
Z Yearly ROA, ROE, ROICZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2 -4 -6 -8

1.3 Margins

The Gross Margin of Z (76.44%) is better than 89.23% of its industry peers.
In the last couple of years the Gross Margin of Z has grown nicely.
Z does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y42.3%
GM growth 5Y9.85%
Z Yearly Profit, Operating, Gross MarginsZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

7

2. Health

2.1 Basic Checks

Z does not have a ROIC to compare to the WACC, probably because it is not profitable.
Z has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, Z has more shares outstanding
Z has a better debt/assets ratio than last year.
Z Yearly Shares OutstandingZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
Z Yearly Total Debt VS Total AssetsZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 11.64 indicates that Z is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 11.64, Z belongs to the top of the industry, outperforming 90.77% of the companies in the same industry.
The Debt to FCF ratio of Z is 3.23, which is a good value as it means it would take Z, 3.23 years of fcf income to pay off all of its debts.
Z has a Debt to FCF ratio of 3.23. This is amongst the best in the industry. Z outperforms 83.08% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that Z is not too dependend on debt financing.
The Debt to Equity ratio of Z (0.04) is better than 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 3.23
Altman-Z 11.64
ROIC/WACCN/A
WACC8.62%
Z Yearly LT Debt VS Equity VS FCFZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

2.3 Liquidity

A Current Ratio of 2.46 indicates that Z has no problem at all paying its short term obligations.
Z has a better Current ratio (2.46) than 67.69% of its industry peers.
Z has a Quick Ratio of 2.46. This indicates that Z is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.46, Z is in the better half of the industry, outperforming 73.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.46
Quick Ratio 2.46
Z Yearly Current Assets VS Current LiabilitesZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.94% over the past year.
Looking at the last year, Z shows a quite strong growth in Revenue. The Revenue has grown by 14.96% in the last year.
The Revenue has been decreasing by -4.00% on average over the past years.
EPS 1Y (TTM)10.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.89%
Revenue 1Y (TTM)14.96%
Revenue growth 3Y-35.01%
Revenue growth 5Y-4%
Sales Q2Q%13.04%

3.2 Future

Based on estimates for the next years, Z will show a very strong growth in Earnings Per Share. The EPS will grow by 24.42% on average per year.
Z is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.23% yearly.
EPS Next Y25.24%
EPS Next 2Y30.45%
EPS Next 3Y34.18%
EPS Next 5Y24.42%
Revenue Next Year14.75%
Revenue Next 2Y14.74%
Revenue Next 3Y14.97%
Revenue Next 5Y14.23%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
Z Yearly Revenue VS EstimatesZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
Z Yearly EPS VS EstimatesZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 1 -1 2 3 4

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 54.94, Z can be considered very expensive at the moment.
Based on the Price/Earnings ratio, Z is valued a bit cheaper than the industry average as 66.15% of the companies are valued more expensively.
Z is valuated expensively when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 33.46, which means the current valuation is very expensive for Z.
Compared to the rest of the industry, the Price/Forward Earnings ratio of Z indicates a somewhat cheap valuation: Z is cheaper than 75.38% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of Z to the average of the S&P500 Index (21.76), we can say Z is valued expensively.
Industry RankSector Rank
PE 54.94
Fwd PE 33.46
Z Price Earnings VS Forward Price EarningsZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of Z is on the same level as its industry peers.
Z's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 102.93
EV/EBITDA 175.3
Z Per share dataZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates Z does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as Z's earnings are expected to grow with 34.18% in the coming years.
PEG (NY)2.18
PEG (5Y)N/A
EPS Next 2Y30.45%
EPS Next 3Y34.18%

0

5. Dividend

5.1 Amount

No dividends for Z!.
Industry RankSector Rank
Dividend Yield N/A

ZILLOW GROUP INC - C

NASDAQ:Z (7/11/2025, 8:00:02 PM)

After market: 78.05 +0.04 (+0.05%)

78.01

-0.9 (-1.14%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)07-31 2025-07-31/amc
Inst Owners95.7%
Inst Owner Change-0.02%
Ins Owners6.74%
Ins Owner Change10.75%
Market Cap18.84B
Analysts72.67
Price Target81.55 (4.54%)
Short Float %8.21%
Short Ratio6.83
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.61%
Min EPS beat(2)-7.25%
Max EPS beat(2)8.47%
EPS beat(4)3
Avg EPS beat(4)15.53%
Min EPS beat(4)-7.25%
Max EPS beat(4)42.57%
EPS beat(8)7
Avg EPS beat(8)37.17%
EPS beat(12)11
Avg EPS beat(12)82.15%
EPS beat(16)14
Avg EPS beat(16)32.86%
Revenue beat(2)0
Avg Revenue beat(2)-0.35%
Min Revenue beat(2)-0.4%
Max Revenue beat(2)-0.3%
Revenue beat(4)2
Avg Revenue beat(4)1.58%
Min Revenue beat(4)-0.4%
Max Revenue beat(4)4.31%
Revenue beat(8)6
Avg Revenue beat(8)2.17%
Revenue beat(12)9
Avg Revenue beat(12)-1.47%
Revenue beat(16)10
Avg Revenue beat(16)-22.99%
PT rev (1m)-6.69%
PT rev (3m)-10.27%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-14.78%
EPS NY rev (1m)0.28%
EPS NY rev (3m)-6.58%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)-0.65%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.12%
Valuation
Industry RankSector Rank
PE 54.94
Fwd PE 33.46
P/S 8.17
P/FCF 102.93
P/OCF 41.67
P/B 3.96
P/tB 11.53
EV/EBITDA 175.3
EPS(TTM)1.42
EY1.82%
EPS(NY)2.33
Fwd EY2.99%
FCF(TTM)0.76
FCFY0.97%
OCF(TTM)1.87
OCFY2.4%
SpS9.55
BVpS19.69
TBVpS6.77
PEG (NY)2.18
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.41%
ROE -1.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.44%
FCFM 7.94%
ROA(3y)-1.95%
ROA(5y)-2.59%
ROE(3y)-2.68%
ROE(5y)-4.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y42.3%
GM growth 5Y9.85%
F-Score6
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 3.23
Debt/EBITDA 1.77
Cap/Depr 104.26%
Cap/Sales 11.67%
Interest Coverage N/A
Cash Conversion 461.22%
Profit Quality N/A
Current Ratio 2.46
Quick Ratio 2.46
Altman-Z 11.64
F-Score6
WACC8.62%
ROIC/WACCN/A
Cap/Depr(3y)73.5%
Cap/Depr(5y)73.95%
Cap/Sales(3y)7.76%
Cap/Sales(5y)5.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.89%
EPS Next Y25.24%
EPS Next 2Y30.45%
EPS Next 3Y34.18%
EPS Next 5Y24.42%
Revenue 1Y (TTM)14.96%
Revenue growth 3Y-35.01%
Revenue growth 5Y-4%
Sales Q2Q%13.04%
Revenue Next Year14.75%
Revenue Next 2Y14.74%
Revenue Next 3Y14.97%
Revenue Next 5Y14.23%
EBIT growth 1Y35.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year430.25%
EBIT Next 3Y96.32%
EBIT Next 5Y59.16%
FCF growth 1Y-82.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-62.49%
OCF growth 3YN/A
OCF growth 5YN/A